This article was originally published in The Gray Sheet
Receives 510(k) clearance for its handheld ultrasound imaging device May 8 covering 11 clinical applications including obstetrical, gynecological, abdominal and cardiovascular imaging. The company, spun off from ATL Ultrasound on April 6 ("The Gray Sheet" May 11, p. 23), plans to introduce the product initially in the women's health care market in the second half of 1999 pending finalization of product design, the firm explains. Battery-powered and weighing under 10 pounds, the device is expected to sell for under $20,000...
You may also be interested in...
Will the second wave of coronavirus lockdown have the same impact on the European consumer health industry? Speaking exclusively to HBW Insight from Germany, Merz Consumer Care CEO Frank Baldauf thinks not. Recently investing in premium beard care brand Brooklyn Soap and launching its tetesept Formula range in the Netherlands, Merz's Baldauf suggest that there will be less panic buying this time round and the CHC supply chain will hold up under pressure.
After a strong first quarter, Japan’s Towa Pharmaceuticals saw stability in its domestic revenues but a drop in revenues from its overseas business in its financial second quarter. After launching a series of molecules in June 2020, the company has lined up 10 launches for December 2020 as well.
Pfizer has revealed launch plans for its Nyvepria pegfilgrastim biosimilar, shortly after receiving formal European Commission approval.